Brian Meshkin named an Emerging Technology CEO finalist in the Orange County Technology Alliance’s 2016 High-Tech Innovation Awards

July 21, 2016 0 Comments

IRVINE, CALIF. (July 21, 2016) — Proove Biosciences, Inc. is proud to announce that its founder and CEO, Brian Meshkin, has been named an Emerging.

Three New Profiles to Help Clinicians Improve Treatment

July 11, 2016 0 Comments

Proove Biosciences, Inc. is pleased to announce the introduction of three new evidence-based tests to support better clinical decision-making for difficult-to-treat conditions that are influenced.

Proove Biosciences and Specialty Health Announce a Positive Coverage Determination by Leading Nevada Insurer for Genetic Testing

April 13, 2016 0 Comments

Proove Biosciences and Specialty Health are excited to announce a positive policy decision on the use of Proove Genetic testing to achieve the quadruple aim.

Proove Biosciences Launches Expanded Drug Metabolism Profile to Help Doctors Prescribe Heart Medications with Greater Precision

April 11, 2016 0 Comments

Proove Biosciences, Inc., the commercial and research leader in personalized pain medicine, is excited to announce the launch of its expanded Proove Drug Metabolism™ Genetic.